PeDRA 2025Abstract 073Clinical trial
INTEGUMENT-INFANT: A Phase 2, 4-Week Open-Label Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less than 2 Years With Mild-to-Moderate Atopic Dermatitis
Hebert AA, Eichenfield LF, Gonzalez ME, Paller A, Browning JC, Funk T, Kempers SE, Prajapati VH, Serrao R, Swanson L, Lee LW, Hanna D, Nolte J, Kato S, Burnett P
PeDRA Annual Conference 2025Minneapolis, 9–11 Oct 2025 · published in JID 9 Mar 2026
Topics: Atopic dermatitis & eczemaPediatric dermatology
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/s0022-202x(26)00608-1 · Not in PubMed: details from Crossref